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S U M M A R Y
Background: Helicobacter pylori gastric colonization is known to be high in symptomatic subjects.
However, only a few reports on the presence of H. pylori in the esophageal mucosa have been published.
The aim of this study was to assess the frequency of H. pylori in the esophagus of dyspeptic patients and
its association with histopathology.
Methods: The presence of H. pylori in the gastroesophageal mucosa was detected by ﬂuorescence in situ
hybridization (FISH) and PCR analysis of DNA extracted from gastric and esophageal biopsies of 82
symptomatic patients, using genus- and species-speciﬁc PCR primers. Alterations in the gastroesopha-
geal mucosa were assessed by conventional histological techniques.
Results: H. pylori in the stomach was detected by PCR and FISH, respectively, in 61% (n = 43) and 90%
(n = 63) of dyspeptic patients, and in the esophagus in 70% (n = 44) and 73% (n = 46). The prevalence of
cagA-positive strains by PCR varied from 50% (n = 35) in the gastric mucosa to 65% (n = 41) in the
esophageal mucosa. By combining the results of both methods, H. pylori was present in the
gastroesophageal mucosa in 86% (n = 68) of patients. The association of the presence of bacteria,
including H. pylori, in the esophageal mucosa with histopathological alterations was statistically
signiﬁcant between microabscesses and bacteria (r = 0.656, p < 0.0001) and PCR detection and
pseudogoblet cells (r = 0.25, p < 0.047).
Conclusions: This is the ﬁrst report of the occurrence of H. pylori in the esophageal mucosa from
dyspeptic Venezuelan patients. These results demonstrate the high prevalence of H. pylori in the
esophagus, and its presence was correlated with signs of inﬂammation.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Colonizing bacteria play a role in a variety of disease conditions,
as exempliﬁed by Helicobacter pylori in the human stomach.1 H.
pylori infection has been implicated as the main cause of peptic
ulceration, gastric lymphoma, and gastric adenocarcinoma, the
second leading cause of death from cancer worldwide.2 Coloniza-
tion of H. pylori occurs in childhood and persists throughout life.3
Infection with H. pylori occurs worldwide, but the geographical
prevalence varies greatly, exceeding 90% in developing countries
compared to 20% to 50% in developed countries.4* Corresponding author. Tel.: +58 212 5041855; fax: +58 212 5041093.
E-mail address: mocontre@ivic.gob.ve (M. Contreras).
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doi:10.1016/j.ijid.2012.01.007In Venezuela, the prevalence of gastric infection with H. pylori is
known to be high, with reported prevalences ranging from 38% to
95% in the asymptomatic population,5 and 46% to 95% in
symptomatic patients.6–10 These prevalences have been deter-
mined by different detection methods, such as rapid biopsy urease
test and histology, PCR, PCR–denaturing gradient gel electropho-
resis analysis (DGGE), enzyme-linked immunosorbent assay
(ELISA), and line probe assay (LiPA) techniques. The prevalence
appears to be inversely proportional to socioeconomic status.6
The esophagus is a potential environment for bacterial
colonization: alterations of the microenvironment, such as reﬂux
esophagitis, Barrett’s esophagus, and esophageal carcinoma, could
affect the bacterial biota. The H. pylori status of the gastric contents
could also alter the upstream esophageal biota, due to its effects on
gastric acidity and reﬂux.11,12 In developed countries only a fewses. Published by Elsevier Ltd. All rights reserved.
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esophageal mucosa,13–17 and in Venezuela, a developing country
with a high prevalence of H. pylori infection, its incidence has not
yet been reported. The aim of this study was to determine the
occurrence of H. pylori in the gastric and esophageal mucosa of
dyspeptic patients, to assess its presence in the esophageal mucosa
using PCR and ﬂuorescence in situ hybridization (FISH) biopsy-
based methods, and to investigate its association with histopatho-
logical alterations.
2. Materials and methods
2.1. Clinical specimens
Patients attending the Center for the Control of Gastric Cancer
(San Cristo´bal, Venezuela) and the Gastroenterology Service of the
Hospital Pe´rez Carren˜o (Caracas, Venezuela) with gastrointestinal
symptoms of dyspepsia requiring upper gastrointestinal endoscopy
were recruited into this study. The volunteers were informed of the
study objectives and completed a questionnaire regarding occupa-
tion, diet, and hygiene habits. Patients who had received antibiotics,
antacids, or a proton pump inhibitor in the previous month were
excluded from the study. Eighty-two volunteers participated in the
study; 39 subjects were from the city of San Cristo´bal: 21 male and
18 female (age range 18–66 years, mean age 45 years), and 43
subjects were from Caracas: 22 male and 21 female (age range 18–78
years, mean age 49 years). Informed consent was obtained from each
patient, and the study was approved by the Bioethics Committee of
the Instituto Venezolano de Investigaciones Cientı´ﬁcas (IVIC). Two
paired biopsy specimens of the gastric mucosa (antrum) and
esophageal mucosa (lower third or within 2 cm of the Z-line) were
collected from each patient. For each mucosa, one biopsy was
immediately placed in formalin for histopathology and FISH, and the
other biopsy was submitted for PCR assays. Biopsies were taken with
care to avoid inter-sample contamination.
2.2. Histopathology
All biopsy specimens submitted for histopathology analysis
were ﬁxed in formalin and embedded in parafﬁn. Sections of 4 mm
in thickness were obtained and adhered onto glass slides, dewaxed
in xylene, and subsequently rehydrated with phosphate buffered
solution at pH 7.4 (PBS). The sections were used for FISH and
conventional histopathology. Factors indicating gastritis, e.g.,
neutrophil inﬁltration and lymphoplasmacytic inﬁltration, were
graded according to the semiquantitative ordinal scale of the
updated Sydney classiﬁcation for the stomach (antrum) for
normal, mild, moderate, and severe inﬂammation, with a scoring
system from 0 to 3, respectively.18 In addition, the presence of
malgun (clear) cells was taken as indicative of alterations induced
by H. pylori. These cells were recognized in the proliferative and
surface zones of the pyloric mucosa based on the following
characteristics: nuclear enlargement, euchromatin pattern, con-
spicuous nucleoli, and expanded cytoplasm with decreased
stainability on HE staining.19 The patterns of inﬂammation in
the esophagus were characterized using the following character-
istics: dysplasia, metaplasia, basal hyperplasia, plasma cell,
lymphocyte, mononuclear cell, and neutrophil inﬁltration, and
microabscesses.20 The specimens were coded to ensure complete
blind examination of the slides.
2.3. Helicobacter genus-speciﬁc and H. pylori-speciﬁc PCR assays
DNA was extracted from the gastric and esophageal biopsy
specimens of 82 symptomatic subjects. A total of 164 DNA samples
were processed using the QIAamp DNA Mini Kit (Qiagen, Valencia,CA, USA). Helicobacter DNA was detected using a genus-speciﬁc
PCR assay for the 16S rRNA gene.21 The presence of H. pylori DNA
was assessed using speciﬁc assays targeting the glmM gene and the
cagA gene.22,23 PCRs were performed using the Ready To-Go PCR
Beads Kit (Amersham Biosciences Corp., USA) and a thermal cycler
(model GeneAMP PCR System 9700, Applied Biosystems, USA),
using the same cycling conditions as originally described for each
pair of primers. Each reaction contained PCR reagents plus 3–6 ml
of the extracted DNA solution, 3 ml primer mix (5 mM), and sterile
distilled water for a ﬁnal volume of 25 ml. Two positive controls
were used as a template for each PCR assay: an H. pylori strain
isolated from a Venezuelan patient with gastritis and H. pylori
26695. The negative control was a no-template PCR reaction.
2.4. rRNA gene sequencing and sequence analysis
We randomly chose one gastric and one esophageal biopsy DNA
specimen positive for Helicobacter for ampliﬁcation and sequenc-
ing of the 16S rRNA gene by nested PCR, as described previously.24
The ﬁrst set consisted of external universal primers (8F and
1525R),24 and the internal primers were a Helicobacter genus-
speciﬁc primer (HeliF) and another targeting the Epsilon branch of
Proteobacteria (EpsilR),21 yielding 1288-bp amplicons. Sequences
were compared with the 16S rRNA gene sequences available in the
GenBank nucleotide library by BLAST search of NCBI (http://
www.ncbi.nlm.nih.gov). The 16S rRNA gene sequences of gastric
(1185 bp) and esophageal (1237 bp) biopsy DNA specimens were
deposited in GenBank under the accession numbers HM046431
and HM046432, respectively.
2.5. Fluorescence in situ hybridization (FISH)
FISH was performed on gastric and esophageal biopsy sections
as described by Trebesius et al.25 Brieﬂy, the following treatments
were performed before FISH: 264 mM sodium borohydride for
20 min, 0.01% Triton X for 10 min, and 25% proteinase K for 5 min.
Three rinses with PBS at room temperature were performed
between each step. Four ﬂuorescent oligonucleotide probes
targeting the 16S rRNA gene were used: two Helicobacter genus-
speciﬁc probes, HEL274 and HEL717 (both Cy3–50 labeled),26 an H.
pylori-speciﬁc probe,25 Hpy-1 (Cy3–50 labeled), and a probe for the
universal bacteria domain EUB338 (Alexa Fluor 488 N-50 labeled)
as a positive control to simultaneously visualize the bacteria
within intact tissue samples.27 The probes were commercially
synthesized by Integrated DNA Technologies (Dallas, TX, USA).
Hybridization was performed at 54 8C for 90 min and stringent
washing at 56 8C for 10 min, according to the protocol of Trebesius
et al.25 The bacteria were visualized with a Nikon Eclipse E600 epi-
ﬂuorescence microscope and images were digitally acquired by a
Nikon Coolpix 8700 camera. Probe speciﬁcity was veriﬁed by
evaluating positive and negative controls (e.g., slide prepared from
a clinical strain culture of H. pylori and a slide prepared from a
culture of Shigella sp (ATCC11126), respectively). The ﬁxation of
control strains was performed as described by Samarbaf-Zadeh
et al.28 Positive hybridizations were visible as orange or red whole-
cells, where they hybridize with both the EUB338 (green) probe
and the Hpy-1 (red) probe for the speciﬁc detection of H. pylori, and
the Hpy-1 (red) probe, respectively.
2.6. Statistical analysis
To detect correlations between different histopathological
parameters and the detection of H. pylori by PCR and FISH, we
performed a Spearman’s rank correlation. p-Values of <0.05 were
considered signiﬁcant. The presence of a histopathological
variable, grade-independent, was considered as positive (= 1).
M. Contreras et al. / International Journal of Infectious Diseases 16 (2012) e364–e370e3663. Results
PCR and FISH methodologies for H. pylori detection in the
studied population were performed for 79 out of the 82 patients.
Histopathological study of the stomach antral and esophageal
biopsies was performed for 70 and 63 patients, respectively, out of
the 82 patients (Supplementary Material, Tables S1 and S2). In the
12 and 19 remaining patients, there was not enough stomach and
esophagus mucosal tissue left after the FISH analysis for
histopathology. Therefore, the results of gastric H. pylori infection
are presented for 70 patients and those for esophageal infection are
reported for 63 patients, for whom all three methods (histopa-
thology, FISH, and PCR) were performed.
3.1. Histology of the gastric and esophageal mucosa
Nineteen out of 70 patients (27%) had a normal appearing
gastric mucosa, whereas 51 (73%) showed histopathological
alterations in the antrum (Table 1). Of these, 20 patients (29%)
had varying degrees of superﬁcial gastritis with or without
dysplasia and/or intestinal metaplasia, with inﬁltration and
bacteria being the most frequent alterations. The other 31 patients
(44%) had chronic atrophic gastritis with or without dysplasia and/
or intestinal metaplasia, with metaplasia and bacteria the most
common alterations (Table 1). Other histopathological alterations
associated with gastritis, such as the presence of mucosa-
associated lymphoid tissue (MALT)-like follicles, were observed
in a few patients (Figure 1a, Table 1); these follicles were scarce,
small follicles with few mononuclear cells being predominant. We
also observed neutrophil inﬁltration and necrosis of the epithelium
(Figure 1b). In some cases, there was epithelial metaplasia without
inﬁltration together with a normal appearing epithelium. In
addition, we detected malgun (clear) cells in the atrophic mucosa
(Figure 1c).
In 44 of the 63 (70%) esophageal mucosa samples we found
severe neutrophil inﬁltration, microabscesses, bacteria, dysplasia,
hyperplasia, metaplasia, plasmocytes, and pseudogoblet cells, with
inﬁltration, microabscesses, and bacteria being the most frequent
alterations; 19 (30%) patients had a normal appearing mucosa
(Table 1). The presence of chronic inﬂammation in these 44
patients was evidence of a severe cellular immune response. In the
zones adjacent to microabscesses we observed bacteria in
hematoxylin and eosin (HE)-stained slides (Figure 1d), whichTable 1
Histopathological alterations and their frequencies in gastroesophageal mucosa biopsies
Supplementary Material (Tables S1 and S2)
Histopathological alterations Gastric biopsies (N = 70) 
Superﬁcial gastritisa
(n = 20), n (%)
Chronic atro
(n = 31), n (%
Dysplasia 5 (25%) 12 (39%) 
Metaplasia 9 (45%) 28 (90%) 
Inﬁltration 0 1 (5%) 1 (3%) 
Inﬁltration 1 0 (0) 6 (19%) 
Inﬁltration 2 7 (35%) 11 (35%) 
Inﬁltration 3 12 (60%) 13 (42%) 
Neutrophil inﬁltration 17 (85%) 19 (61%) 
Monocyte inﬁltration 16 (80%) 23 (74%) 
Malgun cells 7 (35%) 10 (32%) 
MALT-like follicles 4 (20%) 6 (19%) 
Bacteria 15 (75%) 25 (81%) 
Microabscesses - - 
Pseudogoblet cells - - 
Hyperplasia - - 
Plasmocytes - - 
MALT, mucosa-associated lymphoid tissue.
a Number of histopathological alterations found in 20 and 31 out of 70 patients acc
b Number of histopathological alterations found in 44 out of 63 patients.were identiﬁed as H. pylori by FISH (Figure 2c,d). Different zones of
the esophageal mucosa presented necrosis and vacuolated
keratinocytes; in some cases bacteria were localized in the
intercellular space (Figure 1d) or intracellular vacuoles
(Figure 1e), which were identiﬁed as H. pylori by FISH
(Figure 2c,d) and in an isolated culture from an esophagus biopsy
specimen (Figure 2e–i). Furthermore, bacteria were also localized
in the submucosa (Figure 1f). Some eosinophils were observed in
the zones inﬁltrated with microabscesses. Destruction of large
areas of the epithelium with abscesses was evident in different
zones, associated with severe inﬁltration of neutrophils in the
vicinity of the basal zone. The presence of H. pylori in the esophagus
was further conﬁrmed in some esophageal biopsies by the
detection of metalloenzyme activity (data not shown).
3.2. Molecular detection of H. pylori in the stomach and the esophagus
Helicobacter DNA in the stomach was detected in 43 of the 70
(61%) symptomatic patients by Helicobacter genus-speciﬁc and H.
pylori species-speciﬁc PCR assays, and in 63 (90%) patients by FISH
(Table 2). The detection of cagA and glmM positivity in the gastric
mucosa by PCR was observed in 35 (50%) and 38 (54%) patients,
respectively. The cagA and glmM genes were not detected in eight
(11%) and ﬁve (7%) of 43 Helicobacter-positive patients, respec-
tively (Table 2). The FISH analysis was carried out on 70 gastric and
63 esophageal biopsy specimens for comparisons with histopath-
ological alterations (Table 2). H. pylori was localized by FISH both in
the mucosa and submucosa (Figure 2a,b). H. pylori was observed as
orange or red whole-cells and distributed in the stomach within
the luminal area and/or close to the surface of the mucus layer
covering the secretory epithelium, adhering to epithelial cells and
among the submucosal cells (Figure 2a,b). The detection by FISH
and PCR for 16S rRNA, glmM and cagA were different, with a higher
number of positives detected by FISH (90%) (Table 2).
Helicobacter DNA in the esophagus was found in 44 (70%) of the
63 patients by PCR and 46 (73%) by FISH (Table 2). Of the 44
patients Helicobacter-positive by PCR, the cagA and glmM genes
were detected in 41 (65%) and 43 (68%) patients, but not in three
(5%) and one (2%) patients, respectively (Table 2). Therefore, a
fragment of the Helicobacter 16S rRNA gene was ampliﬁed and
sequenced (both gastric and esophageal mucosa) from these two
Helicobacter-positive subjects. The sequences obtained were 1185
and 1237 bp in length and were 99% identical to the H. pylori 16S from symptomatic patients. Individual data on a per patient basis are given in the
Esophageal biopsies (N = 63)
phic gastritisa
)
Total
(n = 51), n (%)
(n = 44), n (%)b
17 (33%) 15 (34%)
37 (73%) 14 (32%)
2 (4%) -
6 (12%) -
18 (35%) -
25 (49%) -
36 (71%) 38 (86%)
39 (76%) -
17 (33%) -
10 (20%) -
40 (78%) 18 (41%)
- 19 (43%)
- 8 (18%)
- 15 (34%)
- 9 (20%)
ording to the updated Sydney classiﬁcation for the stomach (antrum).
Figure 1. Gastric and esophageal mucosa biopsy tissue sections, HE stained. (a) Gastric tissue section showing massive inﬁltration of inﬂammatory cells; the asterisk indicates
a MALT-like follicle (bar 40 mm; 20). (b) Leukocyte inﬁltration in the mucosa with necrosis of epithelium (arrows) (bar 40 mm; 20). (c) Image showing the malgun (clear)
cells (arrow) in an inﬁltration zone with foveolitis (bar 10 mm; 100). (d) Image showing bacteria in the extracellular space of the esophageal epithelium (arrows). This zone
is adjacent to microabscesses (bar 10 mm; 100). (e) Vacuolated keratinocytes; the arrows indicate bacteria inside vacuoles (bar 10 mm; 100). (f) Esophageal submucosa;
the arrows indicate bacteria in the submucosa, some adjacent to basal membrane zone (bar 20 mm; 40).
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AY366424). H. pylori cells were identiﬁed in 46 (73%) esophageal
specimens by FISH. The detection by FISH and PCR for 16S rRNA,
glmM, and cagA in the esophagus were comparable, with similar
numbers of positives detected by FISH (73%) and PCR (70%) (Table
2). H. pylori was observed as orange or red whole-cells adhering to
the apical surface of the corniﬁed epithelium, among keratino-
cytes, sometimes surrounded by a clear space. In some specimens,
H. pylori was found in the submucosa in contact with cells of the
immune system.
We found a signiﬁcant correlation between PCR and FISH
detection in the gastric mucosa (Table 3). Analysis of the different
variables in the histopathological study and the detection of H.
pylori by PCR and FISH showed signiﬁcant correlations between
metaplasia and the presence of chronic atrophic gastritis,
inﬁltration 3 and superﬁcial gastritis, inﬁltration 3 and neutrophil
inﬁltration, bacteria and neutrophil inﬁltration, PCR detection for
all three genes (16S rRNA, glmM, and cagA) and neutrophil
inﬁltration, PCR detection for all three genes and inﬁltration 3, and
PCR total and FISH (Table 3).
Furthermore, analysis of the different histological variables in
the esophagus with the presence of bacteria, including H. pylori, as
demonstrated by PCR and FISH, showed signiﬁcant correlations
between microabscesses and basal hyperplasia, microabscesses
and bacteria, basal hyperplasia and bacteria, pseudogoblet cells
and metaplasia, and PCR detection for all three genes (16S rRNA,
glmM and cagA) and pseudogoblet cells (Table 3).
3.3. Detection of H. pylori in both the esophagus and the stomach
The results of the speciﬁc tests for H. pylori infection in the
gastroesophageal mucosa by patient are shown in Table 4. PCRdetection for all three genes (16S rRNA, glmM, and cagA) in the
stomach was correlated with the detection in the esophagus,
showing signiﬁcant correlations (Table 3). The presence of H. pylori
by PCR and/or FISH was determined in 68 (86%) of the 79 patients
where assays were performed in both mucosae, whereas the
presence of H. pylori only in gastric mucosa was found in 72 (91%)
patients.
4. Discussion
The prevalence of H. pylori in the esophageal mucosa was found
to be rather high, with 68 of the 79 (86%) dyspeptic Venezuelan
patients (Table 4). This was correlated with signs of inﬂammation
(i.e., microabscesses and pseudogoblet cells, as shown by Spear-
man’s rank correlations). The persistence of inﬂammation can
induce other changes such as basal hyperplasia and dysplasia.19 H.
pylori and many other bacterial species have been detected in the
esophagus of healthy patients14 and patients with reﬂux-related
diseases29 and Barrett’s esophagus.30,31 We found H. pylori in
association with the epithelium in esophageal biopsies from
symptomatic patients, suggesting that the existence of H. pylori in
the esophagus is probably a consequence of gastric infection rather
than being a prevalent resident species.
In the stomach of patients with active gastritis, the presence of
neutrophils in a mixed inﬂammatory pattern as well as the
presence of malgun (clear) cells is characteristic of H. pylori
gastritis,32 especially when this inﬁltration is conﬁned to the
proliferative zone of the gastric pit, a condition called foveolitis.
We found a correlation between the presence of malgun (clear)
cells and severe neutrophil inﬁltration, as has been reported
previously.19 We also found a correlation between metaplasia and
neutrophil inﬁltration and the presence of glmM and cagA genes of
Figure 2. Detection of Helicobacter pylori by FISH in gastric and esophageal biopsy tissue sections from patients with dyspeptic symptoms. (a) Detection of H. pylori with a
mixture of ﬂuorescent probes, EUB338 (green) probe and Hpy-1 (red) probe, in the gastric mucosa and submucosa. H. pylori is visible in orange (bar 10 mm; 100). (b) Merged
ﬂuorescence and phase contrast image, corresponding to the same section as in image a; arrow points to the bacteria observed in image a (bar 10 mm; 100). (c) Detection of
H. pylori with Hpy-1 (red) probe in the esophageal epithelium. H. pylori is visible in red (bar 10 mm; 100). (d) Merged ﬂuorescence and phase contrast image, corresponding
to the same section as in image c; arrow points to the bacteria observed in image c (bar 10 mm; 100). (e) Detection of H. pylori using the Hpy-1 (red) probe on an isolated
culture from an esophagus biopsy specimen from the same patient whose H. pylori was identiﬁed in images c and d (bar 10 mm; 100). (f)–(i) Images show the different
morphological types of the bacterium. Nuclear staining: DAPI (bar 5 mm; 100).
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morphological changes in the tissue, the most remarkable being
metaplasia,33 and is signiﬁcantly associated with chronic atrophic
gastritis. These changes have been related to intensive oxidative
activity induced by neutrophils, which produce large amounts of
reactive oxygen species (ROS) during host defense reactions.34 One
possibility is that the epithelial changes caused by H. pylori allow
increased nutrient delivery to the bacterium. These host–bacteria
interactions may induce niche modiﬁcation, resulting in betterconditions for the survival of H. pylori and/or worse conditions for
the survival of competing bacteria.2
H. pylori was detected in the stomach (61%) and in the
esophagus (70%) by 16S rRNA, glmM and cagA gene-speciﬁc PCRs
(Table 2). The cagA gene (cytotoxin-associated gene A) is a marker
for the so-called pathogenicity island in H. pylori, the presence of
which is signiﬁcantly correlated with the clinical outcome in
persons carrying the bacterium.7 We found the prevalence of H.
pylori infection (70%) and cagA-positive strains (65%) in the
Table 2
Analysis of histopathology, FISH, and PCR in the gastric and esophageal mucosa
FISH, n (%) PCR, n (%)
16S rRNA 16S rRNA glmM cagA
Positive Negative Positive Negative Positive Negative Positive Negative
Gastric mucosa (n = 70)
Histopathology, n (%)
With alterations 51 (73%) 48 (69%) 3 (4%) 33 (47%) 18 (26%) 31 (44%) 20 (29%) 28 (40%) 23 (33%)
Normal 19 (27%) 15 (21%) 4 (6%) 10 (14%) 9 (13%) 7 (10%) 12 (17%) 7 (10%) 12 (17%)
Total 70 63 (90%) 7 (10%) 43 (61%) 27 (39%) 38 (54%) 32 (46%) 35 (50%) 35 (50%)
Esophageal mucosa (n = 63)
Histopathology, n (%)
With alterations 44 (70%) 31 (49%) 4 (6%) 30 (48%) 5 (8%) 29 (46%) 5 (8%) 28 (44%) 6 (10%)
Normal 19 (30%) 15 (24%) 13 (21%) 14 (22%) 14 (22%) 14 (22%) 15 (24%) 13 (21%) 16 (25%)
Total 63 46 (73%) 17 (27%) 44 (70%) 19 (30%) 43 (68%) 20 (32%) 41 (65%) 22 (35%)
FISH, ﬂuorescence in situ hybridization; PCR, polymerase chain reaction.
Table 3
Analysis of signiﬁcant correlations between different histopathological parameters, PCR, and FISH in 70 gastric biopsies (WG) and 63 esophageal biopsies (WE) from 82
patients studied
Comparison among the different variables in the gastroesophageal mucosa Correlation signiﬁcant analysis by Spearman’s rank
r p-Value
Gastric mucosa
Metaplasia and presence of chronic atrophic gastritis 0.669 0.0001
Inﬁltration 3 and superﬁcial gastritis 0.44 0.0006
Inﬁltration 3 and neutrophil inﬁltration 0.576 0.0001
Bacteria and neutrophil inﬁltration 0.37 0.005
PCR detection of 16S rRNA gene and neutrophil inﬁltration 0.337 0.0109
PCR detection of glmM gene and neutrophil inﬁltration 0.423 0.0011
PCR detection of cagA gene and neutrophil inﬁltration 0.433 0.0008
PCR detection of 16S rRNA gene and inﬁltration 3 0.448 0.0005
PCR detection of glmM gene and inﬁltration 3 0.486 0.0001
PCR detection of cagA gene and inﬁltration 3 0.4 0.0023
PCR total (WG) and FISH (WG) 0.431 0.0009
Esophageal mucosa
Microabscesses and basal hyperplasia 0.688 0.0001
Microabscesses and bacteria 0.656 0.0001
Basal hyperplasia and bacteria 0.636 0.0001
Pseudogoblet cells and metaplasia 0.471 0.0002
PCR detection of 16S rRNA gene and pseudogoblet cells 0.25 0.0476
PCR detection of glmM gene and pseudogoblet cells 0.26 0.0395
PCR detection of cagA gene and pseudogoblet cells 0.279 0.0265
Gastroesophageal mucosa
PCR total (WE) and FISH (WG) 0.5246 0.0001
16S rRNA by PCR (WE) and 16S rRNA by PCR (WG) 0.3436 0.0095
glmM by PCR (WE) and glmM by PCR (WG) 0.356 0.007
cagA by PCR (WE) and cagA by PCR (WG) 0.3728 0.0047
FISH, ﬂuorescence in situ hybridization; PCR, polymerase chain reaction.
Table 4
Prevalence of Helicobacter pylori infection in the gastroesophageal mucosa of
dyspeptic patients by PCR and FISH
Detection methods Number of patients (%)
(n = 79)
H. pylori positive by PCR and/or FISH
in the gastroesophageal mucosa
68 (86.1%)
H. pylori positive by PCR and FISH
only in the gastric mucosa
4 (5.1%)
No infection 7 (8.9%)
FISH, ﬂuorescence in situ hybridization; PCR, polymerase chain reaction.
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(29% to 74%) as those reported in patients with reﬂux-related
diseases, Barrett’s esophagus, and gastric and esophageal adeno-
carcinomas using other diagnostic techniques such as histology
and serology for H. pylori.15–17
The prevalence of H. pylori (61%) and cagA-positive strains (50%)
as detected by PCR in the gastric mucosa is in accordance with
previous reports (58–95%) in Venezuelan populations7–9 and from
other geographic regions.35,36 H. pylori virulence-associated
genotypes change with geographic and ethnic variables.35,37 This
has been described for cagA-positive status where the prevalence
varies from 22% to 90% in populations of different countries.38
There is a high genetic heterogeneity of H. pylori, even within a
single patient.7,39 In our study, we partially sequenced the 16S
rRNA Helicobacter genus-speciﬁc amplicons from both the gastric
and esophageal mucosa from two different patients whose
samples were glmM- and cagA-negative, thinking that they might
be colonized by a non-pylori Helicobacter. However, the sequences
of 16S rRNA fragments shared 99% identity with the H. pylori 16S
rRNA gene. Polymorphisms and the existence of distinct cagAvariants that appear to be highly conserved (>95% at the
nucleotide level) may have been responsible for the failure to
detect these genes in these gastroesophageal biopsies.7,40
FISH in each mucosa detected H. pylori infection in more cases
than PCR – in an additional 20 cases in stomach and two cases in
esophagus (Table 2). This discrepancy between the PCR and FISH
results might be explained by the fact that the distribution of H.
pylori is not uniform within tissues, with a patchy distribution
M. Contreras et al. / International Journal of Infectious Diseases 16 (2012) e364–e370e370throughout the mucosa.41 Although the two biopsies were taken
close to one another, the presence of bacteria in each biopsy and/or
tissue section could be different. In fact, the extensive examination
of three tissue sections from both mucosae by ﬂuorescence
microscopy led to the identiﬁcation of H. pylori by FISH, as has been
reported for gastric biopsy specimens.25,28,42,43
H. pylori was found in both mucosae of the same subject in 86%,
while it was detected in only one mucosa in 91% of the patients.
Finally, this is the ﬁrst report of the occurrence of H. pylori in the
esophageal mucosa of dyspeptic patients in the developing world.
These results demonstrate the high prevalence of H. pylori in the
esophagus, and its presence was correlated with signs of
inﬂammation; however, this association deserves further investi-
gation to determine whether H. pylori is the direct cause as a result
of gastric infection or whether it is the presence of other pathogen
species producing opportunistic infections. It is interesting to note
that H. pylori eradication in dyspeptic patients may lead to an
increased frequency of histopathological esophagitis.44
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